Necessity of Sequencing Emerging SARS-CoV-2 Variants from UK and... With the emergence of the new B.1.1.7 (UK) and B.1.351 (Sout... by Behind The Bench Staff / 01.19.2021 Read More Necessity of Sequencing Emerging SARS-CoV-2 Variants from UK and S. Africa
Podcast: Benefits of Targeted NGS for SARS-CoV-2 Epidemiology an... While molecular methods like quantitative polymerase chain r... by Behind The Bench Staff / 01.14.2021 Read More Podcast: Benefits of Targeted NGS for SARS-CoV-2 Epidemiology and Lessons Learned
Enabling GPCR Research with GPCR Antibodies Written by Nora Marbaniang, Raghul Mathivanan & Amir Kha... by Behind The Bench Staff / 01.06.2021 Read More Enabling GPCR Research with GPCR Antibodies
Solutions for surveillance of the S gene mutation in the B.1.1.7... The recent news that a highly transmissible SARS-CoV-2 strai... by Behind The Bench Staff / 12.31.2020 Read More Solutions for surveillance of the S gene mutation in the B.1.1.7 (501Y.V1) SARS-CoV-2 strain lineage
Thermo Fisher’s COVID-19 tests: designed with virus mutations ... Updated December 30, 2020: While the B.1.1.7 variant has be... by Behind The Bench Staff / 12.24.2020 Read More Thermo Fisher’s COVID-19 tests: designed with virus mutations in mind
Targeted NGS Reveals Two Distinct Immune Responses to SARS-CoV-2... Emerging biomarkers of immune responses to SARS-CoV-2 infect... by Behind The Bench Staff / 12.10.2020 Read More Targeted NGS Reveals Two Distinct Immune Responses to SARS-CoV-2 Infection from Postmortem Lung Tissue
